Yanbo Luo1, Fenglin Sun1, Xiaowen Peng2, Dong Dong3, Wentao Ou3, Yongke Xie3, Yuqi Luo1. 1. Department of Gastrointestinal and Hepatobiliary Surgery, Shenzhen Longhua District Central Hospital, Shenzhen, 518110, Guangdong, People's Republic of China. 2. Department of Laboratory Medicine, Nansha Hospital, Guangzhou First People's Hospital, School of Medicine, Southern China University of Technology, Guangzhou, Guangdong, 511457, People's Republic of China. 3. Department of General Surgery, Nansha Hospital, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 511457, Guangdong, People's Republic of China.
Abstract
OBJECTIVE: To identify the value of key differentially expressed genes (DEGs) regulated by differentially methylated regions (DMRs) in predicting the prognosis of human colon cancer. MATERIALS AND METHODS: RNA sequencing data and DNA methylation data of 455 colon adenocarcinoma (COAD) cases and 41 normal controls were downloaded from The Cancer Genome Atlas (TCGA). Gene Ontology (GO) functional enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed by the DAVID database. To identify the hub genes regulated by methylation, univariate Cox and multivariate Cox regression analyses were carried out. A nomogram based on the risk score was built to identify the power of the hub genes to predict prognosis in patients with colon cancer. RESULTS: A total of 133 DEGs regulated by DMRs were identified through analyzing RNA sequencing data and DNA methylation data from TCGA. GO functional enrichment and KEGG pathway enrichment analysis showed the genes involved in the initiation and progression of colon cancer. Univariate Cox regression analysis and multivariate Cox regression analysis focused on the seven hub genes (CDH4, CR2, KRT85, LGI4, NPAS4, RUVBL1 and SP140) associated with overall survival, the expression of which negatively correlated with their methylation level. The risk score and nomogram model showed that the hub genes served as potential biomarkers for the prognosis prediction of patients with colon cancer. CONCLUSION: Our findings suggest that the DEGs regulated by DMRs are involved in the carcinogenesis and development of colon cancer, and the aberrantly methylated DEGs associated with overall survival of patients may be potential diagnostic and therapeutic targets for colon cancer.
OBJECTIVE: To identify the value of key differentially expressed genes (DEGs) regulated by differentially methylated regions (DMRs) in predicting the prognosis of human colon cancer. MATERIALS AND METHODS: RNA sequencing data and DNA methylation data of 455 colon adenocarcinoma (COAD) cases and 41 normal controls were downloaded from The Cancer Genome Atlas (TCGA). Gene Ontology (GO) functional enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed by the DAVID database. To identify the hub genes regulated by methylation, univariate Cox and multivariate Cox regression analyses were carried out. A nomogram based on the risk score was built to identify the power of the hub genes to predict prognosis in patients with colon cancer. RESULTS: A total of 133 DEGs regulated by DMRs were identified through analyzing RNA sequencing data and DNA methylation data from TCGA. GO functional enrichment and KEGG pathway enrichment analysis showed the genes involved in the initiation and progression of colon cancer. Univariate Cox regression analysis and multivariate Cox regression analysis focused on the seven hub genes (CDH4, CR2, KRT85, LGI4, NPAS4, RUVBL1 and SP140) associated with overall survival, the expression of which negatively correlated with their methylation level. The risk score and nomogram model showed that the hub genes served as potential biomarkers for the prognosis prediction of patients with colon cancer. CONCLUSION: Our findings suggest that the DEGs regulated by DMRs are involved in the carcinogenesis and development of colon cancer, and the aberrantly methylated DEGs associated with overall survival of patients may be potential diagnostic and therapeutic targets for colon cancer.
Authors: Akiko Doi; In-Hyun Park; Bo Wen; Peter Murakami; Martin J Aryee; Rafael Irizarry; Brian Herb; Christine Ladd-Acosta; Junsung Rho; Sabine Loewer; Justine Miller; Thorsten Schlaeger; George Q Daley; Andrew P Feinberg Journal: Nat Genet Date: 2009-11-01 Impact factor: 38.330
Authors: Ying Hu; Samuel W French; Thinh Chau; Hui-Xin Liu; Lili Sheng; Fang Wei; Jesse Stondell; Juan C Garcia; Yanlei Du; Christopher L Bowlus; Yu-Jui Yvonne Wan Journal: FASEB J Date: 2018-09-25 Impact factor: 5.191
Authors: Xiaoke Hao; Huiyan Luo; Michal Krawczyk; Wei Wei; Wenqiu Wang; Juan Wang; Ken Flagg; Jiayi Hou; Heng Zhang; Shaohua Yi; Maryam Jafari; Danni Lin; Christopher Chung; Bennett A Caughey; Gen Li; Debanjan Dhar; William Shi; Lianghong Zheng; Rui Hou; Jie Zhu; Liang Zhao; Xin Fu; Edward Zhang; Charlotte Zhang; Jian-Kang Zhu; Michael Karin; Rui-Hua Xu; Kang Zhang Journal: Proc Natl Acad Sci U S A Date: 2017-06-26 Impact factor: 11.205
Authors: Lei Xiong; Feng Wu; Qiong Wu; Liangliang Xu; Otto K Cheung; Wei Kang; Myth T Mok; Lemuel L M Szeto; Cheuk-Yin Lun; Raymond W Lung; Jinglin Zhang; Ken H Yu; Sau-Dan Lee; Guangcun Huang; Chiou-Miin Wang; Joseph Liu; Zhuo Yu; Dae-Yeul Yu; Jian-Liang Chou; Wan-Hong Huang; Bo Feng; Yue-Sun Cheung; Paul B Lai; Patrick Tan; Nathalie Wong; Michael W Chan; Tim H Huang; Kevin Y Yip; Alfred S Cheng; Ka-Fai To Journal: Nat Commun Date: 2019-01-18 Impact factor: 14.919